In another recent study, it was seen that the lncRNA CHKB-DT expression was marked as downregulated in DCM, and being a lncRNA related to energy metabolism and mitochondrial dysfunction, CHBK-DT may be a potential therapeutic target for DCM [48]. Here, CHKB-DT is linked to familial dilated cardiomyopathy.